Fluid flow stress affects peritoneal cell kinetics: Possible pathogenesis of peritoneal fibrosis

Peritoneal Dialysis International

Volumn 31, Issue 4, 2011, Pages 466-476

  Aoki, Shigehisa ^a   Makino, Junichi ^b   Nagashima, Akinori ^c   Takezawa, Toshiaki ^d   Nomoto, Namie ^a,e   Uchihashi, Kazuyoshi ^a   Matsunobu, Aki ^a   Sanai, Toru ^a   Sugihara, Hajime ^f   Toda, Shuji ^a  

^a SAGA UNIVERSITY   (Japan)

^b Makino Clinic   (Japan)

^c KARATSU RED CROSS HOSPITAL   (Japan)

^d NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^e NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

^f INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Dialysis solution streaming; Epithelial mesenchymal transition; Fluid flow stress; MAPK; Peritoneal fibrosis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; DIALYSIS FLUID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL KINETICS; CELLULAR STRESS RESPONSE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROGENESIS; FLUID FLOW; FLUID FLOW STRESS; HUMAN; HUMAN CELL; HUMAN TISSUE; MESOTHELIUM CELL; NONHUMAN; PATHOGENESIS; PERITONEAL FIBROSIS; PERITONEUM CELL; PRIORITY JOURNAL; RAT; CELL CULTURE; CYTOLOGY; EPITHELIUM CELL; FLOW KINETICS; HYPERPLASIA; MECHANICAL STRESS; PATHOLOGY; PERITONEAL DIALYSIS; PERITONEUM; PHYSIOLOGY;

CELLS, CULTURED; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; HYPERPLASIA; MITOGEN-ACTIVATED PROTEIN KINASES; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM; RHEOLOGY; STRESS, MECHANICAL;

EID: 84855168796     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2010.00157     Document Type: Article

References (38)

1. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13(Suppl 1):S37-40.
2. Van Biesen W, Vanholder R, Lameire N. The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int 2000; 20:375-83.
3. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20:2587-93.
4. Oreopoulos DG, Khanna R, Wu G. Sclerosing obstructive peritonitis after CADP. Lancet 1983; 2:409.
5. Bradley JA, Hamilton DN, McWhinnie DL, Briggs JD, Junor BJ. Sclerosing peritonitis after CADP. Lancet 1983; 2:572-3.
6. Miyazaki M, Yuzawa Y. The role of peritoneal fibrosis in encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S48-56.
7. Mactier RA. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis. Adv Perit Dial 2000; 16:223-8.
8. Morgan LW, Wieslander A, Davies M, Horiuchi T, Ohta Y, Beavis MJ, et al. Glucose degradation products (GDP) retard remesothelialization independently of-glucose concentration. Kidney Int 2003; 64:1854-66.
9. Nakamura S, Niwa T. Advanced glycation end-products and peritoneal sclerosis. Semin Nephrol 2004; 24:502-5.
10. Mistry CD, Gokal R. Glucose polymer as an osmotic agent in CADP. Adv Exp Med Biol 1989; 260:149-56.
11. Kawanishi H, Shintaku S, Shishida M, Morrishi M, Tsuchiya S, Dohi K. A case of encapsulating peritoneal sclerosis suspected to result from the use of icodextrin peritoneal solution. Adv Perit Dial 2009; 25:45-9.
12. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 2003; 33:129-37.
13. Shav D, Einav S. The effect of mechanical loads in the differentiation of precursor cells into mature cells. Ann Ny Acad Sci 2010; 1188:25-31.
14. Ridge KM, Linz L, Flitney FW, Kuczmarski ER, Chou YH, Omary MB, et al. Keratin8 phosphorylation by protein kinaseC delta regulates shear stress-mediated disassembly of keratin intermediate filaments in alveolar epithelial cells. J Biol Chem 2005; 280:30400-5.
15. Dos Santos CC, Slutsky AS. Invited review: mechanisms of ventilator-induced lung injury: a perspective. J Appl Physiol 2000; 89:1645-55.
16. Davies PF, Dewey CF Jr, Bussolari SR, Gordon EJ, Gimbrone MA Jr. Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells. J Clin Invest 1984; 73:1121-9.
17. Yáñez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348:403-13.
18. Peinado H, Quintanilla M, Cano A. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 2003; 278:21113-23.
19. Selgas R, Bajo A, Jiménez-Heffernan JA, Sánchez-Tomero JA, Del Peso G, Aguilera A, et al. Epithelial-to-mesenchymal transition of the mesothelial cell-its role in the response of the peritoneum to dialysis. Nephrol Dial Transplant 2006; 21(Suppl 2):ii2-7.
20. Sumpio BE, Yun S, Cordova AC, Haga M, Zhang J, Koh Y, et al. MAPKs (ERK1/2, p38) and AKT can be phosphorylated by shear stress independently of platelet endothelial cell adhesion molecule-1 (CD31) in vascular endothelial cells. J Biol Chem 2005; 280:11185-91.
21. Kojda G, Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 2005; 67:187-97.
22. Aoki S, Takezawa T, Uchihashi K, Sugihara H, Toda S. Non-skin mesenchymal cell types support epidermal regeneration in a mesenchymal stem cell or myofibroblast phenotype-independent manner. Pathol Int 2009; 59:368-75.
23. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993; 85:200-6.
24. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23:530-41.
25. Araki Y, Hataya H, Tanaka Y, Fukuzawa R, Ikeda M, Kawamura K, et al. Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children. Perit Dial Int 2000; 20:445-51.
26. Kawaguchi Y, Saito A, Kawanishi H, Nakayama M, Miyazaki M, Nakamoto H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 2005; 25(Suppl 4):S83-95.
27. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S43-55.
28. Xu ZG, Kim KS, Park HC, Choi KH, Lee HY, Han DS, et al. High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells. Kidney Int 2003; 63:958-68.
29. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139:871-90.
30. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11:556-64.
31. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62:1046-53.
32. Stel VS, Dekker FW, Ansell D, Augustijn H, Casino FG, Collart F, et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant 2009; 24:3175-82.
33. Szeto CC, Wong TY, Chow KM, Leung CB, Law MC, Li PK. Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients. Perit Dial Int 2004; 24:58-64.
34. Blake PG. Adequacy of dialysis revisited. Kidney Int 2003; 63:1587-99.
35. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
36. Johnson DW, Cho Y, Livingston BE, Hawley CM, McDonald SP, Brown FG, et al. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int 2010; 77:904-12.
37. Brown MC, Simpson K, Kerssens JJ, Mactier RA. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol 2009; 4:1222-9.
38. Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl 2003; (84):S158-61.